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ABSTRACT
Objectives: To assess the effectiveness of a rapid second trimester test for cervical phIGFBP-1 in the prediction of sponta-
neous preterm delivery prior to 34 weeks in asymptomatic twin pregnancies.
Material and methods: A prospective observational study conducted on 232 twin pregnancies tested for phIGFBP-1 at 
20–24 weeks of gestation. 151 patients assessed as asymptomatic, with cervical length > 25 mm at 20–24 weeks were 
analysed. The primary outcome was the delivery < 34 weeks of gestation. 
Results: The spontaneous preterm delivery before completing 34 weeks occurred in 23 patients (15.2%), including 9 in 
dichorionic and 14 in monochorionic pregnancies. The sensitivity of phIGFBP-1 test was 0.39 and specificity 0.63 in predicting 
delivery before 34 gestational weeks. phIGFBP-1 had a low positive predictive value of 0.16 and high negative predictive 
value (0.85). Both positive and negative predictive values of delivery < 34 weeks were close to 1.
Conclusions: A test for phIGFBP1 presence is not an effective additional tool for predicting preterm delivery before 
34 weeks in twin gestation.
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INTRODUCTION
Preterm delivery affects about 2/3 of all twin pregnancies 
and accounts for about 50% of all neonatal deaths [1–5]. In 
the Preterm Prediction Study, 54.4% of all twins were born 
prior to 37 weeks, 32% before 35 weeks and 8.8% before 
completing 32 weeks of gestation [3]. The problem of pre-
maturity in a constantly growing number of twins increases 
the social and public health expenses, however the biggest 
medical problems and financial outlays are intended for twins 
born before 34 gestational weeks [6]. Several biochemical 
markers have been proposed to predict preterm delivery 
in both symptomatic and asymptomatic pregnant women, 
including cervical phosphorylated insulin-like growth factor 
binding protein-1 (phIGFBP-1). IGFBP-1 is a 25-kDa hydropho-
bic protein [7]. Its phosphorylated form is produced mainly 
by decidual cells and is present between the chorion and 
decidua. When the cervix matures for delivery, the chorion 
and decidua detach and phIGFBP-1 leeks into the cervical 
secretion. In 2001 Kekki et al. reported that phIGFBP-1 pre-
sence in cervical secretion is a predictor of preterm delivery 
[8]. A commercial bedside test for phIGFBP-1 is available in 
Europe. In comparison to fetal fibronectin (fFN) it has the 
advantage of being unaffected by recent sexual intercourse 
or urine presence, and the cost of the test is lower [8, 9]. Its 
efficiency as a predictor of preterm delivery in singleton pre-
gnancies has been widely discussed in the literature [10–12]. 
phIGFBP-1 is especially useful in identifying symptomatic 
women in singleton pregnancies who will not deliver within 
48 hours [10]. However, its efficacy in the prediction of pre-
term delivery in twin gestations is uncertain. 
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Objectives
The aim of our study was to assess the effectiveness 
of a rapid test for cervical phIGFBP-1 performed in the se-
cond trimester in the prediction of spontaneous preterm 
delivery before 34 gestational weeks in asymptomatic twin 
pregnancies.
MATERIAL AND METHODS
A prospective observational study was conducted at 
the 1st Department of Obstetrics and Gynecology, Medical 
University of Warsaw, between 2012 and 2015. 232 women 
prior to 16 weeks of twin gestation were enrolled after giving 
an informed written consent. Gestational age and chorioni-
city were confirmed in the first trimester ultrasound scan. 
There were 84 women in monochorionic diamniotic and 
148 in dichorionic pregnancies. Patients in monoamniotic 
pregnancies were initially excluded from the study due to 
a specific risk of preterm delivery. Women in dichorionic 
pregnancies were counselled routinely once every 4 weeks 
and in monochorionic pregnancies once every 2 weeks, 
including an ultrasound scan. In cases with no pregnancy 
complications both monochorionic and dichorionic twins 
were delivered beyond 37 weeks of gestation according to 
the local policy. During the observational period 7 patients 
miscarried and 6 had twin-to-twin transfusion syndrome 
(TTTS), therefore they were excluded from further analy-
sis. All women were counselled between 20 and 24 weeks 
of gestation. A routine ultrasound scan assessing fetal bio-
metry and anatomy were performed during that period and 
an ultrasound measurement of the length of cervical canal 
was performed. It was measured according to Fetal Medicine 
Foundation recommendations — transvaginal probe was 
placed in the anterior fornix of the vagina with an empty 
bladder and the linear distance between calipers placed at 
the internal and external cervical os was taken. At the same 
time, between 20 and 24 gestational weeks, cervical swab 
samples were collected with a special kit and the presence 
of phIGFBP-1 was evaluated by an immunoenzymometric 
assay (Actim Partus, Medix Biochemica). According to the 
manufacturer the test is positive when phIGFBP-1 reaches 
the concentration of 10 μg/L. Cervical secretion samples 
were obtained by inserting a sterile swab into the cervical 
canal for 15 seconds. The swab was swirled in the extraction 
solution for 10 seconds. After the extraction the test dipstick 
was placed in the solution. It was checked after five minutes: 
if the two lines (control line and test line) appeared, the test 
was considered positive. If only test line appeared, the test 
was negative. There were no cases of failed tests with no 
test line visible.
There were 20 patients diagnosed with cervical length 
less than 25 mm between 20 and 24 gestational weeks and 
they had Arabin pessary inserted and/or vaginal progester-
one administered. In 1 case of amniotic membranes pro-
truding through external os of the cervix a rescue cerclage 
was performed. In 2 cases preterm premature rupture of 
membranes occurred prior to 24 weeks of gestation and in 
2 other intrauterine fetal demise was diagnosed. In order to 
avoid bias all those patients were further excluded from the 
analysis. No clinical interventions were introduced on the 
basis of the analyzed phIGFBP-1 test results.
The primary outcome of the study was delivery occur-
ring before completed 34 weeks of gestation. Secondary 
outcomes included deliveries prior to 37 (preterm delive-
ry) and 32 weeks of gestation. In order to minimize bias 
all patients delivered before 37 completed weeks due to 
medical indications were also excluded from the study. 
Only patients who developed spontaneous regular uterine 
contractions and afterwards delivered both vaginally and 
via caesarean section were taken into analysis. Six patients 
were lost to follow-up. Finally there were 151 asymptomatic 
patients eligible for analysis — none of them were admini-
stered vaginal progesterone. The diagram illustrating the 
study population is presented in Figure 1. 
The following variables were included in the analysis: 
patients’ age, parity, chorionicity, pre-pregnancy body mass 
index (BMI), gestational weight gain, the use of assisted 
reproduction techniques (ART), gestational age at testing, 
ultrasound assessment of cervical length and gestational 
age at delivery. Data on pregnancy outcome and delivery 
were obtained from hospital records. BMI was calculated by 
dividing the body mass by the square of the body height. 
Gestational weight gain was calculated by subtraction of 
the pre-gravid weight from final weight measured before 
delivery. 
The study obtained the approval of the Ethics Commit-
tee of Medical University of Warsaw and was conducted 
according to the Declaration of Helsinki.
Variables are described as mean (± SD), median or per-
centage. The Mann–Whitney test (for continuous variables) 









37 delivered < 36 weeks due 
to medical indications, 2lUDs
6 lost to follow-up
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and the Fisher’s exact test (for percentages) were used for 
the statistical analysis. p-values < 0.05 were considered 
significant. Sensitivity, specificity, positive predictive value, 
negative predictive value and positive and negative likeli-
hood ratio with 95% confidence intervals were calculated 
to test the predictive value for preterm delivery (before 32, 
34 and 37 weeks of gestation) of the phIGFBP-1 test. Data 
were analysed using Statistica version 13.1.
RESULTS
The mean gestational age at testing for phIGFBP-1 was 
22.4 weeks (20–24 weeks). The mean gestational age at 
delivery was 35.4 weeks. The spontaneous preterm deli-
very before completing 34 weeks occurred in 23 patients 
(15.2%), including 9 in dichorionic and 14 in monochorionic 
pregnancies. 93 patients delivered before 37 gestational 
weeks (61.6%), 9 prior to 32 weeks (6%) and 2 patients 
before 28 weeks of gestation (1.3%). In the group of dicho-
rionic twin pregnancies 56 (58.3%) were delivered before 
37, 9 (9.2%) before 34, 4 (4.1%) before 32 and none before 
28 weeks of gestation. Among monochorionic twins deli-
very before 37 weeks occurred in 37 cases (69.8%), before 
34 weeks in 14 cases (26.4%), before 32 weeks in 11 cases 
(20.8%) and before 28 in 2 cases (3.8%). Basic characteristics 
of patients studied and those delivering < 34 and ≥ 34 weeks 
are presented in Table 1. 
Patients delivering < 34 weeks of gestation had shor-
ter cervical length on mid-trimester ultrasound scan, but 
the difference was on the border of statistical significance 
(p = 0.05) and similar occurrence of positive phIGFBP-1 test 
between 20 and 24 weeks to those delivering beyond 34 we-
eks (p = 0.8). Women delivering beyond 37 gestational 
weeks had significantly longer cervical length on ultraso-
und scan (p = 0.02) and less often positive phIGFBP-1 test 
(p < 0.001). 
In the study group 56 patients were tested positive for 
IGFBP-1 (37.1%). 46 of them delivered preterm spontane-
ously (82.1%), 9 < 34 weeks (16.1%), 5 < 32 weeks (8.9%) and 
2 < 28 weeks of gestation (3.6%). Among 95 women with 
negative IGFBP-1 test 47 delivered before completing 37 we-
eks of gestation (49.5%), 14 < 34 weeks (14.7%), 4 < 32 weeks 
(4.2%) and none < 28 gestational weeks.
The performance of the phIGFBP-1 test in predicting 
preterm delivery is reported in Table 2. The sensitivity 
was 0.39 and specificity 0.63 in predicting delivery before 
34 gestational weeks. phIGFBP-1 had a low positive pre-
dictive value (PPV) of 0.16 and high negative predictive 
value (0.85). Both positive and negative predictive values of 
delivery < 34 weeks were close to 1. phIGFBP-1 had similar 
performance of the test in predicting PTD in monochorionic, 
as well as dichorionic pregnancies. The test had moderate 
sensitivity (0.5) and high specificity (0.83) in prediction of 
delivery before 37 weeks. Having a positive phIGFBP-1 test 
in mid-pregnancy has a positive predictive value of 2.87 of 
delivering before 37 gestational weeks.
DISCUSSION
This study proves that phIGFBP-1 test has a low sensi-
tivity if performed between 20 and 24 weeks of gestation 
in predicting delivery before 34 weeks in asymptomatic 
women in twin gestation. Although the negative predictive 
value (NPV) for the delivery < 34 weeks was high (0.85), it 
Table 1. Basic characteristics of the study group and group of patients delivering < 34 and ≥ 34 weeks
Study group
n = 151
Delivery ≥ 34 weeks
n = 128
Delivery < 34 weeks
n = 23
average ± SD
* n (%) 95% CI
average ± SD
*n (%) 95% CI
average ± SD 
*n (%) 95% CI p
Age (years) 30.8 ± 4.1 30.1–31.4 30.7 ± 4.2 30–31.55 31.2 ± 3.4 29.8–32.6 0.6
Primiparous* 93 (61.6%) 74 (57.8%) 19 (82.6%) 0.02














BMI [kg/m2] 23.4 ± 3.9 22.8–24 23.7 ± 3.9 23–24.4 21.8 ± 3.3 20.3–23.2 0.04
Gestational weight gain [kg] 17.6 16.7-18.5 18.1  ± 4.9 17.3-19 14.5  ± 7.3 11.4–17.7 0.002
ART* 42 (27.8%) 37 (28.9%) 5 (21.7%) 0.4
Cervical length (mm) 34.2 ± 4.8 33.5–35 35 ± 4.7 33.8–35.4 32 ± 5.1 29.7–34.3 0.05
Positive phIGFB-1 test* 56 (37.1%) 47 (36.7%) 9 (39.1%) 0.8
Caesarean delivery* 127 (84.1%) 104 (81.3%) 23 (100%)
SD — standard deviation; 95% CI — 95% coefficient interval; BMI — body mass index; ART — pregnancies after assisted reproductive techniques
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was similar to the rate of deliveries < 34 weeks in the study 
group (15.2%), suggesting no additional benefits in clinical 
practice. The results were similar in both monochorionic and 
dichorionic groups separately.
According to our results the risk of preterm delivery 
was 61.6%. In patients with positive result of IGFBP-1 test 
the probability of delivery before 37 weeks has risen almost 
3-times, while in patients with negative test results the risk 
has decreased to 37.6%. Patients in dichorionic pregnancies 
with positive test were 3-times more likely to deliver pre-
term, while patients in monochorionic pregnancies about 
2.4-times more likely to deliver before 37 weeks of gestation. 
Although the efficacy of phIGFBP-1 test in prediction of 
preterm delivery has been widely studied, the data on its 
effectiveness among patients in twin gestation is scarce. 
Several studies included women both in singleton and twin 
gestations, however separate results for twin pregnancies 
were not presented [8, 13–16]. There are only two published 
researches on twins. In 2010 Adeyemi and Osoba published 
a retrospective study including patients in twin pregnan-
cies. 40 asymptomatic women had phIGFBP-1 test perfor-
med at 26 weeks of gestation. According to their results the 
patients with a negative phIGFBP-1 test had a low risk of 
delivery before 34 weeks in the absence of other obstetric 
complications, as only 7.5% of all women with a negative test 
result delivered < 34 weeks of gestation. Only 2 women had 
a positive test result (5%) — one of them delivered < 34 we-
eks and the other > 37 weeks of gestation [17].
The second research by Fichera et al. was a prospective 
cohort study published in 2014. 197 asymptomatic wo-
men in twin pregnancies were tested for phIGFBP-1 at the 
time of ultrasound fetal anatomy scan. 10.7% of patients 
delivered < 34 gestational weeks. Reported phIGFBP-1 test 
sensitivity and specificity for the delivery < 34 weeks were 
0.14 and 0.92, respectively. Neither positive nor negative 
test result changed the risk of the delivery < 34 weeks signi-
ficantly. Positive and negative likelihood ratios were both 
inadequate for clinical use (+LR 1.79, 95% CI: 0.56–5.74; –LR 
0.93, 95% CI: 0.78–1.1) [18]. In our study the percentage of 
patients delivering < 34 weeks was similar (15.2%) and the 
test result also did not significantly change the risk of the 
delivery < 34 weeks, as both positive and negative likeli-
Table 2. Sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), positive likelihood ratio (+LR+) and negative 






















Study group (n = 151)
Delivery < 34
phIGFBP-1 0.39 (0.21–0.6) 0.63 (0.6–0.67) 0.16 (0.09–0.25) 0.85 (0.81–0.9) 1.07 (0.53–1.81) 0.96 (0.6–1.31)
Delivery < 37
phIGFBP-1 0.5 (0.43–0.54) 0.83 (0.73–0.91) 0.82 (0.72–0.9) 0.5 (0.44–0.55) 2.87 (1.57–5.7) 0.61 (0.51–0.79)
Delivery < 32
phIGFBP-1 0.53 (0.28–0.77) 0.65 (0.62–0.67) 0.14 (0.08–0.21) 0.93 (0.89–0.96) 1.51 (0.74–2.36) 0.72 (0.34–1.16)
Dichorionic pregnancies (n = 98)
Delivery < 34
phIGFBP-1 0.11 (0.01–0.48) 0.67 (0.66–0.71) 0.03 (0.01–0.14) 0.89 (0.87–0.93) 0.34 (0.02–1.64) 1.32 (0.74–1.5)
Delivery < 37
phIGFBP-1 0.43 (0.34–0.49) 0.86 (0.74–0.94) 0.8 (0.64–0.91) 0.53 (0.46–0.58) 3 (1.33–7.73) 0.67 (0.55–0.89)
Delivery < 32
phIGFBP-1 0.25 (0.01–0.78) 0.69 (0.68–0.71) 0.03 (0.01–0.1) 0.96 (0.94–0.99) 0.81 (0.04–2.71) 1.09 (0.3–1.45)
Monochorionic pregnancies (n = 53)
Delivery < 34
phIGFBP-1 0.57 (0.32–0.8) 0.54 (0.45–0.62) 0.31 (0.17–0.43) 0.78 (0.65–0.89) 1.24 (0.59–2.09) 0.8 (0.33–1.51)
Delivery < 37
phIGFBP-1 0.59 (0.49–0.66) 0.75 (0.51–0.91) 0.85 (0.7–0.95) 0.44 (0.31–0.45) 2.38 (1.01–7.46) 0.54 (0.37–0.99)
Delivery < 32
phIGFBP-1 0.64 (0.34–0.87) 0.55 (0.47–0.61) 0.27 (0.14–0.37) 0.85 (0.73–0.95) 1.41 (0.64–2.22) 0.66 (0.21–1.41)
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hood ratios were similar to those reported by Fichera et al. 
(+LR 1.07, 95% CI: 0.53–1.81; –LR 0.96, 95% CI: 0.6–1.31). 
Similar performance of the test was found for the delivery 
prior to 32 weeks. In both above mentioned studies NPV 
was high and varied between 0.9 and 0.97 for the delive-
ry < 34 and < 28 weeks. Our data are consistent with these 
results (NPV 0.85–0.93 for the delivery < 34 and < 32 weeks). 
In our study phIGFBP-1 test was found to be a useful tool for 
the prediction of preterm delivery generally (+LR 2.87, 95% 
CI: 1.57–5.7), which was not investigated by the previous au-
thors. However as the most of twin gestations are delivered 
prior to 37 weeks, the efficacy of the test in prediction of 
preterm delivery is of less importance.
 The strength of our study is a well characterised 
cohort of patients in twin gestations from a single cen-
tre with defined management protocols. All patients were 
tested during a limited time interval at 20–24 weeks of 
gestation. The use of commercially available test for phIG-
FBP-1 presence is essential in clinical practice. The limitations 
of the study include a small sample size and lack of blindness 
of the test results for the managing clinicians. To avoid bias 
we excluded patients who had Arabin pessary or cervical 
cerclage applied and there were no clinical decisions made 
on the phIGFBP-1 test result. 
CONCLUSIONS
In conclusion, a test for phIGFBP1 presence in mid-pre-
gnancy is not an effective additional tool for predicting 
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